{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:48:17Z","timestamp":1760384897379,"version":"3.35.0"},"reference-count":57,"publisher":"Royal College of Psychiatrists","issue":"5","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"unspecified","delay-in-days":13969,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1979,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Apomorphine, a direct-acting dopamine agonist, stimulates release of growth hormone (hGH) and suppresses release of prolactin (PRL) from the anterior pituitary. Previous studies comparing the magnitude of these responses in schizophrenics and controls suggest that many acute (and some chronic) schizophrenics have exaggerated hGH responses; many chronic schizophrenics (and patients with tardive dyskinesia) have blunted hGH responses to apomorphine, and possibly blunted PRL responses. The present studies extend and confirm these findings in chronic schizophrenics; in addition, several studies were undertaken to further characterize these apomorphine-induced endocrine responses. Studies in which apomorphine was given on 2 or 3 separate occasions to each of five subjects indicate that the hGH response is a highly reproducible individual index, but PRL suppression is a less satisfactory measure. hGH responses to apomorphine were consistently antagonized by pretreatment with haloperidol, supporting the concept that the hGH-releasing effect of apomorphine is mediated by its action on dopamine receptors. Cyproheptadine pretreatment was associated with erratic increases or decreases in the hGH response to apomorphine, but did not alter PRL levels or apomorphine-induced PRL suppression. The relationship of these findings to biological hypotheses of schizophrenia and to neuroleptic-induced receptor changes is discussed.<\/jats:p>","DOI":"10.1192\/bjp.135.5.444","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T22:35:43Z","timestamp":1218580543000},"page":"444-456","source":"Crossref","is-referenced-by-count":50,"title":["Neuroendocrine Effects of Apomorphine: Characterization of Response Patterns and Application to Schizophrenia Research"],"prefix":"10.1192","volume":"135","author":[{"given":"John","family":"Rotrosen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burton","family":"Angrist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Gershon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne","family":"Paquin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Branchey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvin","family":"Oleshansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frieda","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Sachar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"S000712500004383X_ref55","article-title":"Alcohol stimulation of prolactin release from perfused isolated rat pituitary cells","volume":"37","author":"Thorner","year":"1978","journal-title":"Federation Proceedings"},{"key":"S000712500004383X_ref54","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770220081009"},{"key":"S000712500004383X_ref53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(25)25945-6","article-title":"Antiserotonin-anti-histaminic properties of cyproheptadine","volume":"131","author":"Stone","year":"1961","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"S000712500004383X_ref51","doi-asserted-by":"publisher","DOI":"10.1126\/science.184.4143.1243"},{"key":"S000712500004383X_ref50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107732"},{"key":"S000712500004383X_ref48","article-title":"The effect of GABA and muscimol on plasma prolactin in male rats","volume":"37","author":"Simonovic","year":"1978","journal-title":"Federation Proceedings"},{"key":"S000712500004383X_ref45","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(78)90230-8"},{"key":"S000712500004383X_ref39","doi-asserted-by":"publisher","DOI":"10.1210\/endo-102-2-531"},{"key":"S000712500004383X_ref38","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-39-1-1"},{"volume-title":"Psychopharmacology: A Generation of Progress","year":"1978a","author":"Meltzer","key":"S000712500004383X_ref34"},{"key":"S000712500004383X_ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197306282882606"},{"key":"S000712500004383X_ref52","doi-asserted-by":"crossref","unstructured":"Spitzer R. L. , Endicott J. & Robins E. (1977) Research Diagnostic Criteria for a Selected Group of Functional Disorders, 3rd edition.","DOI":"10.1037\/t04137-000"},{"key":"S000712500004383X_ref23","unstructured":"Kafka M. S. & Van Kammen D. P. (1978) Reduced cAMP production in schizophrenia. Presented at 131st Annual Meeting of the American Psychiatric Association, Atlanta, Georgia, May."},{"key":"S000712500004383X_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(78)90407-1"},{"key":"S000712500004383X_ref37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108139"},{"key":"S000712500004383X_ref56","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(78)90415-0"},{"key":"S000712500004383X_ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-197603000-00008"},{"key":"S000712500004383X_ref43","article-title":"Suppression of prolactin by dopamine agonists in schizophrenics and controls","volume":"135","author":"Rotrosen","year":"1978a","journal-title":"American Journal of Psychiatry"},{"key":"S000712500004383X_ref10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.39.9.870"},{"key":"S000712500004383X_ref41","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-40-2-240"},{"key":"S000712500004383X_ref24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-37-5-719"},{"key":"S000712500004383X_ref40","article-title":"Postsynaptic supersensitivity in schizophrenia","volume":"134","author":"Pandey","year":"1977","journal-title":"American Journal of Psychiatry"},{"key":"S000712500004383X_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(77)91291-8"},{"key":"S000712500004383X_ref27","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-44-4-766"},{"key":"S000712500004383X_ref47","first-page":"47","volume-title":"Non-parametric Statistics for the Behavioural Sciences.","author":"Siegel","year":"1956"},{"key":"S000712500004383X_ref42","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426313"},{"key":"S000712500004383X_ref35","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760160102021"},{"key":"S000712500004383X_ref12","article-title":"Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum","volume":"135: 7","author":"Friend","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"S000712500004383X_ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1967.tb09604.x"},{"key":"S000712500004383X_ref30","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-40-1-162"},{"key":"S000712500004383X_ref57","article-title":"Involvement of gamma-aminobutyric acid in the control of gonadotropin and prolactin release in conscious female rats","volume":"37","author":"Vijayan","year":"1978","journal-title":"Federation Proceedings"},{"key":"S000712500004383X_ref32","article-title":"Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?","volume":"32","author":"Matthysse","year":"1973","journal-title":"Federation Proceedings"},{"key":"S000712500004383X_ref33","volume-title":"Frontiers in Neuroendocrinology","volume":"4","author":"McLeod","year":"1976"},{"key":"S000712500004383X_ref28","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-45-5-996"},{"key":"S000712500004383X_ref18","doi-asserted-by":"crossref","unstructured":"Horrobin D. F. (1977) Schizophrenia as a prostaglandin deficiency disease. Lancet, 936\u20137. April 30.","DOI":"10.1016\/S0140-6736(77)92228-0"},{"key":"S000712500004383X_ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-41-3-431"},{"key":"S000712500004383X_ref29","article-title":"Preliminary report on coated charcoal immunoassay of human chorionic \u2018growth hormone-prolactin\u2019 and growth hormone","volume":"123","author":"Laue","year":"1966","journal-title":"Proceedings of the Society of Experimental Biology and Medicine"},{"key":"S000712500004383X_ref1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.127.6.591"},{"key":"S000712500004383X_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(78)90040-1"},{"key":"S000712500004383X_ref21","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-32-6-857"},{"key":"S000712500004383X_ref49","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-36-3-509"},{"key":"S000712500004383X_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(77)90467-2"},{"key":"S000712500004383X_ref44","first-page":"14","article-title":"Neuroendocrine studies with dopamine agonists in schizophrenia","volume":"14","author":"Rotrosen","year":"1978b","journal-title":"Psychopharmacology Bulletin"},{"key":"S000712500004383X_ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750190059011"},{"key":"S000712500004383X_ref17","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770250110011"},{"key":"S000712500004383X_ref22","article-title":"Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data: Part I: \u2018Neuroleptic activity spectra\u2019 for rats","volume":"15","author":"Janssen","year":"1965","journal-title":"Arzneimittel-Forschung"},{"volume-title":"Psychopharmacology: A Generation of Progress","year":"1978","author":"Sachar","key":"S000712500004383X_ref46"},{"key":"S000712500004383X_ref26","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-41-5-827"},{"volume-title":"Psychopharmacology: A Generation of Progress","year":"1978","author":"Aghajanian","key":"S000712500004383X_ref2"},{"key":"S000712500004383X_ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-40-3-363"},{"key":"S000712500004383X_ref6","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.135.2.164"},{"key":"S000712500004383X_ref7","doi-asserted-by":"publisher","DOI":"10.1042\/bj1270143"},{"key":"S000712500004383X_ref9","doi-asserted-by":"publisher","DOI":"10.1007\/BF00403900"},{"key":"S000712500004383X_ref16","doi-asserted-by":"publisher","DOI":"10.1038\/270357a0"},{"key":"S000712500004383X_ref19","article-title":"Increased plasma levels of growth hormone during infusion of propranolol","volume":"28","author":"Imura","year":"1968","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"S000712500004383X_ref20","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-36-1-204"},{"key":"S000712500004383X_ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1975.tb01535.x"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S000712500004383X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T12:23:23Z","timestamp":1738326203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S000712500004383X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,11]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1979,11]]}},"alternative-id":["S000712500004383X"],"URL":"https:\/\/doi.org\/10.1192\/bjp.135.5.444","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"type":"print","value":"0007-1250"},{"type":"electronic","value":"1472-1465"}],"subject":[],"published":{"date-parts":[[1979,11]]}}}